Stress and critical illness: The integrated immune/hypothalamic- pituitary-adrenal axis response

Journal of Intensive Care Medicine

Volumn 12, Issue 5, 1997, Pages 225-238

  Torpy, David J ^a   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYTOKINE; GLUCOCORTICOID; HYDROCORTISONE;

ADRENERGIC SYSTEM; AUTOIMMUNITY; CIRCADIAN RHYTHM; CRITICAL ILLNESS; FEEDBACK SYSTEM; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0030770353     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1177/088506669701200503     Document Type: Review

References (144)

1. Bernard G. Lecons sur les phénomènes de la vie communs aux animaux et aux végétaux, vol 1. Paris: J.B. Baillière et Fils, 1878/79: 111-114; 123-124
2. Cannon W. The wisdom of the body. New York: Norton, 1932
3. Selye H. General adaptation syndrome and the diseases of adaptation. J Clin Endocrinol 1946;6:117-230
4. Curling TB. On acute ulceration of the duodenum in cases of burns. Trans Med-Chir Soc Lond 1842;25:260
5. Carroll BJ, Feinberg M, Greden JF, et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility. Arch Gen Psychiatry 1981; 38:15-22
6. Gold P, Chrousos G, Kellner C, et al. Psychiatric implications of basic and clinical studies with CRF. Am J Psychiatry 1984;141:619-627
7. Boumpas DT, Chrousos GP, Wilder RL, et al. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-1208
8. Bamberger CM, Bamberger A-M, de Castro M, Chrousos GP. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995;95:2435-2441
9. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Rev 1996;17:245-261
10. Udelsman R, Ramp J, Gallucci WT, et al. Adaptation during surgical stress. A reevaluation of the role of glucocorticoids. J Clin Invest 1986;77:1377-1381
11. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev 1984;5:25-44
12. Sack RL, Lewy AJ, Blood ML, et al. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab 1992;75:127-134
13. Desir D, Van Cauter E, Fang VS, et al. Effects of "jet-lag" on hormonal patterns. I. Procedures, variations in total plasma proteins, and disruption of adrenocorticotropin- cortisol periodicity. J Clin Endocrinol Metab 1981;52: 628-641
14. Orth DN, Kovacs WJ, Dehold CR. The adrenal cortex. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology, ed. 8. Philadelphia: W.B. Saunders, 1992: 489-619
15. Levin N, Shinsako J, Dallman M. Corticosterone acts on the brain to inhibit adrenalectomy-induced adrenocorticotropin secretion. Endocrinology 1988;122:694-701
16. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocrine Rev 1984;5:1-24
17. Reincke M, Allolio B, Wurth G, Winkelmann W. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing homone. J Clin Endocrinol Metab 1993;77:151-156
18. Petrides JS, Mueller GP, Kalogeras KT, et al. Exercise- induced activation of the hypothalamic-pituitary-adrenal axis: marked differences in the sensitivity to glucocorticoid suppression. J Clin Endocrinol Metab 1994;79:377-383
19. Gomez T. Magiakou MA, Mastorakos G, Chrousos GP. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing's syndrome. J Clin Endocrinol Metab 1993;77:173-177
20. Edwards CRW, Stewart PM, Burt D. et al. Localization of 11-beta-hydroxysteroid dehydrogenase tissue-specific protector of the mineralocorticoid receptor. Lancet 1988; 2:986-989
21. McEwen BS, de Kloet ER, Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986; 66:1121-1118
22. Reul JHM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985;117:2505-2411
23. Gaillard R, Riondel A, Muller AF, et al. RU 486: a steroid with anti-glucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 1984;81:3879-3882
24. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213:1394-1397
25. De Bold CR, Sheldon WR, DeCherney GS, et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest 1984;73:533-538
26. Schurmeyer TH, Avgerinos PC, Gold PW, et al. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose response of plasma adrenocorticotropin and Cortisol secretion. J Clin Endocrinol Metab 1984; 59:1103-1108
27. Schulte HM, Chrousos GP, Oldfield DH, et al. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. Horm Res 1985;21:69-74
28. Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991;325:897-905
29. Schulte HM, Chrousos GP, Avgerinos P, et al. The corticotropin releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. J Clin Endocrinol Metab 1984;58:1064-1067
30. Saper CB, Lowey AD, Swanson LW, Cowan WM. Direct hypothalamic-autonomic connections. Brain Res 1976;117: 305-312
31. Valentino RJ, Foote SL. Corticotropin releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus ceruleus neurons in unanesthetized rats. J Neurosci 1988;8:1016-1025
32. Kalin NH. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys. Fed Proc 1985; 44:249-253
33. Koob GF, Bloom FE. Corticotropin-releasing factor and behavior. Fed Proc 1991;44:259-263
34. Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive function: role of endogenous corticotropin releasing factor. Science 1986;231:607-609
35. Sutton RE, Koob GF, Le Moal M, et al. Corticotropin releasing factor produces behavioural activation in rats. Nature 1982;297:331-333
36. Aguilera G, Millan MA, Hauger RL, Catt KJ. Corticotropin- releasing factor receptors: distribution and regulation in brain and peripheral tissues. Ann NY Acad Sci 1987; 512:48-66
37. Krishnan KRR, Doraiswamy PM, Lurie SN, et al. Pituitary size in depression. J Clin Endocrinol Metab 1991;72: 256-259
38. Amsterdam J, Marinelli D, Arger P, Winokur A. Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study. Psychiatry Res 1987;21:189-197
39. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to neurobiology of stress. N Engl J Med 1988;319:348-353;413-420
40. Nemeroff CB, Owens MJ, Bissette G, et al. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988;45:577-579
41. Raadsheer FC, Hoogendijk WJG, Stam FC, et al. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994;60:436-444
42. Ur E, Grossman A. Corticotropin-releasing hormone in health and disease: an update. Acta Endocrinol 1992; 127:193-199
43. Makino S, Gold PW, Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 1994;657:141-149
44. Geradoti TD Jr, Orth DN, Ekhator NN, et al. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab 1992;74:1325-1330
45. Chang CP, Pearse R II, O'Connell S, Rosenfeld MG. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993;11:1187-1195
46. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993;90:8967-8971
47. Perrin MH, Donaldson CJ, Chen R, et al. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993;133:3058-3061
48. Vita N, Laurent P, Lefort S, et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 1993; 335:1-5
49. Potter E, Sutton S, Donaldson C, et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994;91: 8777-8781
50. Lovenberg TW, Chalmers DT, Liu C, De Souza EB. CRF (2 alpha) and CRF (2 beta) receptor mRNAs are differentially distributed between the rat CNS and peripheral tissues. Endocrinology 1995;136:3351-3355
51. Perrin M, Donaldson C, Chen R, et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995;92:2969-2973
52. Vaughan J, Donaldson C, Bittencourt J, et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287-292
53. Muglia L, Jacobson L, Dikkes P, Majzoub J. Corticotropin- releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995;373:427-432
54. 2 receptor complementary deoxyribonucleic acid. Endocrinology 1996;137:72-77
55. Donaldson CJ, Sutton SW, Perrin MH, et al. Cloning and characterization of human urocortin. Endocrinology 1996; 137:2167-2170
56. Behan DP, Heinrichs SC, Troncosa JC, et al. Displacement of corticotropin-releasing factor from its binding protein as a possible treatment for Alzheimers disease. Nature 1995; 378:284-287
57. Pardridge WM. Receptor-mediated peptide transport through the blood-brain barrier. Endocrine Rev 1986;7: 314-330
58. Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 1982;4: 275-325
59. Whitnall MH. Stress selectively activates the vasopressin- containing subset of corticotropin-releasing hormone neurons. Neuroendocrinology 1989;50:702-707
60. Holmes MC, Antoni FA, Aguilera G, Gatt KJ. Magnoeellular axons in passage through the the median eminence release vasopressin. Nature 1986;319:326-329
61. Hashimoto K, Suemaru S, Takao T, et al. Corticotropin- releasing hormone and pituitary-adrenocortical responses in chronically stressed rats. Regul Pept 1988;23:117- 126
62. Harbuz MS, Lightman SL. Stress and the hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. J Enclocrinol 1992;134:327-339
63. Spencer RL, McEwen BS. Adaptation of the hypothalamo- pituitary-adrenal axis to chronic ethanol stress. Neuroendocrinology 1990;52:481-489
64. Scribner KA, Walker C, Cascio CS, Dallman MF. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 1991;129:99-108
65. Plotsky PM. Pathways to the secretion of adrenocorticotropin: a view from the portal. J Neuroendocrinol 1991;3: 1-9
66. Canny BJ, Funder JW, Clarke IJ. Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress specific manner. Endocrinology 1989;125:2532-2539
67. Engler D, Pham T, Fullerton MJ, et al. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Neuroendocrinology 1989;49: 367-381
68. Caraty A, Grino M, Locatelli A, et al. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious rams. J Clin Invest 1990;85:1716-1721
69. Jia LG, Canny BJ, Orth DN, Leong DA. Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. Endocrinology 1991;128:197-203
70. Aguilera G, Hardwood JP, Wilson JX, et al. Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. J Biol Chem 1983;258:8039-8045
71. Donald RA, Alexander SL, Ellis MJ, et al. Regulation of corticotrophin secretion. Clin Sci (Colch) 1995;88:4-7
72. Al-Damluji S, Perry L, Tomlin S, et al. Alpha adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 1987;45:68-76
73. Torpy DJ, Grice JE, Hockings GI, et al. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. J Clin Endocrinol Metab 1993;76:388-391
74. Delitala G, Grossman A, Besser GM. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology 1983;37:275-279
75. Al-Damluji S, Rees LH. The neuroendocrine control of corticotropin secretion in normal humans and in Cushing's disease. In: Collu R, Brown GM, Van Loon GR, eds. Clinical neuroendocrinology. Oxford, Blackwell Press, 1988; 251-286
76. Liposits Z, Phelix C, Paull WK. Electron microscopic analysis of tyrosine hydroxylase, dopamine-β-hydroxylase and phenylethanolamine-N-methyltransferase immunoreactive innervation of the hypothalamic paraventricular nucleus in the rat. Histochemistry 1986;84:105-120
77. Cummings S, Elde R, Ells J, Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 1983;3:1355-1368
78. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251
79. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17: 138-146
80. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: implications for the effect of stress on immunity and the Th1/Th2 balance. Proc Assoc Am Physicians 1996;108:374-381
81. Lemer BH. Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes 1949-1961. Ann Intern Med 1996;124;673-680
82. Cohen S, Tyrrell DA, Smith AP. Psychological stress and the common cold. N Engl J Med 1991;325:606-612
83. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Ann Rev Immunol 1995;13:307-338
84. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune mediated inflammation. N Engl J Med 1995; 332:1351-1562
85. Magiakou MA, Mastorakos G, Rabin D. et al. Hypothalamic corticotropin releasing hormone suppression during the postpartum period: implications for the increase of psychiatric manifestations in this period. J Clin Endocrinol Metab 1996;81:1912-1917
86. Kowaki G, Gottschall PE, Somogyvari-Vigh A, et al. Rapid increase in plasma IL-6 after hemorrhage, and posthemorrhage reduction of the IL-6 response to LPS in conscious rats: interrelations with plasma corticosterone levels. Neuroimmunomodulation 1994;1:127-134
87. van Gool J, van Vugt H, Helle M, Aarden LA. The relation among stress, adrenaline, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990;57: 200-210
88. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11:443-449
89. Mastorakos G, Chrousos GP, Weber J. Recombinant interleukin-6 activates the hypothalamic-pituitary adrenal axis in humans. J Clin Endocrinol Metab 1993;77:1690- 1694
90. Mastorakos G, Weber JS, Magiakou MA, et al. Hypothalamic-pituitary-adrenal axis activation and stimulation of vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 1994; 79:934-939
91. Bernton EW, Beach LE, Holaday JW, et al. Release of multiple hormones by a direct effect of interleukin-1 on pituitary cells. Science 1987;238:519-521
92. Fukata J, Usui T, Naitoh Y, et al. Effects of recombinant interleukin-1α, 1β, -2 and -6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 1988;122:33-39
93. Salas MA, Evans SW, Levell MJ, Whicker JT. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol 1990;79:470-473
94. Solomon S. Corticostatins. Trends Endocrinol Metab 1993; 4:260-264
95. Culman J, Tschope C, Jost N, et al. Substance P and neurokinin A induced desensitization to cardiovascular and behavioral effects: evidence for the involvement of different tachykinin receptors. Brain Res 1993;625:75-83
96. Jessop DS, Chowdrey HS, Larsen PJ, Lightman S. Substance P: multifunctional peptide in the hypothalamo-pituitary system? J Endocrinol 1992;132:331-337
97. Larsen PJ, Jessop D, Patel H, et al. Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J Neuroendocrinol 1993;5:99-105
98. Besedovsky H, Sorkin E. Network of immune-neuroendocrine interactions. Clin Exp Immunol 1977;27:1-12
99. Craddock CG. Corticosteroid-induced lymphopenia, immunosuppression and body defense. Ann Intern Med 1978; 88:564-566
100. Calogero AE, Stemberg EM, Bagdy G, et al. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 1992;55:600-608
101. Patchev VK, Kalogeras KT, Zelazowski P, et al. Increased plasma concentrations, hypothalamic output, and in vivo release of arginine vasopressin in inflammatory disease- prone, hypothalamic corticotropin-releasing hormone- deficient Lewis rats. Endocrinology 1992;131:1453-1457
102. Wick G, Hu Y, Schwarz S, Kroemer G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrine Rev 1993;14:539-563
103. Neeck G, Federlin K, Graef V, et al. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990;17:24-29
104. Chikanza IC, Petrou P, Kingsley G. et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35:1281-1288
105. Crofford LJ, Sano H, Karalis K, et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol 1993; 151:1587-1596
106. Crofford LJ, Sano H, Karalis K, et al. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest 1992;90:2555-2564
107. Karalis K, Crofford L, Wilder RL, Chrousos GP. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology 1995;136: 3107-3112
108. Mastorakos G, Bouzas EA, Silver PB, et al. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology 1995;136:4650-4658
109. Karalis K, Sano H, Redwine J. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254:421-423
110. Scopa CD, Mastorakos G, Friedman TC, et al. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. Am J Pathol 1994;145:1159-1167
111. Allen JB, Blatter D, Calandra GB, Wilder RL. Sex hormone effects on the severity of streptococcal wall-induced polyarthritis in the rat. Arth Rheum 1983;26:560-563
112. Lightman SL. From stress to cognition. Nature 1995; 378:233-234
113. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocrine Rev 1994;15:409-420
114. Haas DA, George SR. Gonadal regulation of corticotropin releasing factor in hypothalamus. Brain Res Bull 1988; 20:361-367
115. Bohler HC Jr, Zoeller RT, King JC, et al. Corticotropin releasing hormone mRNA is elevated in the afternoon of proestrus in the paravocellular paraventricular nuclei of the female rat. Mol Brain Res 1990;8:259-262
116. Peiffer A, Barden N. Estrogen-induced decrease of glucocorticoid receptor messenger ribonucleic acid concentration in rat anterior pituitary gland. Mol Endocrinol 1987;1: 435-440
117. Turner BB. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci 1990;46:1399-1406
118. Turner BB. Sex differences in the binding of type I and type II corticosteroid receptors in rat hippocampus. Brain Res 1992;581:229-136
119. Spratt DI, Cox P, Orav J, et al. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endrocrinol Metab 1993;76:1548-1554
120. Ferin M, Van Vugt DA, Wardlaw SL. The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Rec Prog Horm Res 1984;40:441-485
121. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J Am Med Assoc 1992;267:1244-1252
122. Shivers BD, Harlan RE, Morrell JI, Pfaff DW. Absence of estradiol concentration in cell nuclei of LHRH-immunoreactive neurons. Nature 1983;304:345-347
123. Reichlin S. Neuroendocrinology. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology, ed. 8. Philadelphia: W.B. Saunders, 1992:135-219
124. Kakucska I, Yanping Q, Lechan RM. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone. Endocrinology 1995;136:2795-2802
125. Lee SL, Stewart K, Goodman RH. Structure of the gene encoding thyrotropin releasing hormone. J Biol Chem 1988; 263:16604-16609
126. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989;69:1-32
127. Wade CE, Lindberg JS, Cockrell JI. et al. Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endrocrinol Metab 1988;67:223-227
128. Reincke M, Lehmann R, Karl M, et al. Severe illness. Neuroendocrinology. Ann NY Acad Sci 1996;771:556-569
129. Jurney TH, Cockrell JL. Lindherg JS, et al. Spectrum of serum coScarletrtisol response to ACTH in ICU patients: correlation with degree of illness and mortality. Chest 1987;92:292-295
130. Woolf PD, Cox C, Nichols D, et al. The adrenocortical response to brain injury: correlation with the seventy of neurological dysfunction, effects of intoxication, and patient outcome. Alcohol Clin Exp Res 1990;14:917-921
131. Parker LN, Levin FR, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60:947-952
132. Lephart ED, Baxter CR, Parker CR, Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 1987;64:842-848
133. Rothwell PM, Uwadia ZF, Lawle PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337: 582-583
134. Bilezikjian VM, Blount AL, Vale WW. 1987 The cellular actions of vasopressin in corticotrophs of the anterior pituitary: resistance to glucocorticoid actions. Mol Endocrinol 1977;1:451-458
135. Michelson D, Stone L, Galliven E, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary- adrenal function. J Clin Endocrinol Metab 1994;79:848-853
136. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-1439
137. Baldwin WA. Allo M. Occult hypoadrenalism in critically ill patients. Arch Surg 1993;128:673-676
138. Kidess A, Caplan R, Reynertson R, et al. Transient corticotropin deficiency in critical illness. Mayo Clin Proc 1993;68: 435-441
139. Merry W, Caplan R, Wickus G, et al. Postoperative acute adrenal failure caused by transient corticotropin deficiency. Surgery 1994;116:1095-1100
140. Schultz CH, Rivers EP, Feldkamp CS, et al. A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med 1993;21: 1339-1347
141. Almawi WY, Lipman ML, Stevens AC, et al. Abrogation of glucocorticosteroid-mediated inhibition of T cell proliferation by the synergistic action of II-1, 11-6, and IFN-γ. J Immunol 1991;146:3523-3527
142. Kam JC, Szefler SJ, Surs W, et al. Combination IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151:3460-3466
143. Molijn GJ, Koper JW, van Uffelen CJ, et al. Temperature- induced down regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocytes in patients with sepsis or septic shock. Clin Endocrinol (Oxford) 1995;43: 197-203
144. Norbiato G, Bevilacqua M, Vago T, et al. Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:608-613